While chronic inflammation may contribute to pathogenesis of PDs, in the setting of the immunosuppressive tumor microenvironment, Pink1/Prkn deficiency may be beneficial to enhance STING-mediated type I IFN production especially in the setting of mitochondrial stress such as radiation treatment. The gene discussed is PRKN; the disease is neoplasm.